1. 2016
  2. Novel agonists of free fatty acid receptor 1 (GPR40) based on 3-(1,3,4-thiadiazol-2-yl)propanoic acid scaffold

    Krasavin, M., Lukin, A., Zhurilo, N., Kovalenko, A., Zahanich, I. & Zozulya, S., 1 Nov 2016, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 31, 6, p. 1404-1410 7 p.

    Research output: Contribution to journalArticlepeer-review

  3. Gram-scale synthesis of a novel core building block for the new GPR40 agonist design

    Lukin, A., Bagnyukova, D., Zhurilo, N. & Krasavin, M., 1 Aug 2016, In: Letters in Organic Chemistry. 13, 7, p. 491-495 5 p.

    Research output: Contribution to journalArticlepeer-review

  4. Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold

    Krasavin, M., Lukin, A., Zhurilo, N., Kovalenko, A., Zahanich, I., Zozulya, S., Moore, D. & Tikhonova, I. G., 1 Jul 2016, In: Bioorganic and Medicinal Chemistry. 24, 13, p. 2954-2963 10 p.

    Research output: Contribution to journalArticlepeer-review

  5. N-arylation of amidines and guanidines: An update

    Kantin, G. & Krasavin, M., 1 Jun 2016, In: Current Organic Chemistry. 20, 13, p. 1370-1388 19 p.

    Research output: Contribution to journalArticlepeer-review

  6. Current diversity of cyclic anhydrides for the Castagnoli-Cushman-type formal cycloaddition reactions: prospects and challenges

    Krasavin, M. & Dar'in, D., 13 Apr 2016, In: Tetrahedron Letters. 57, 15, p. 1635-1640 6 p.

    Research output: Contribution to journalArticlepeer-review

  7. Keeping it small, polar, and non-flat: diversely functionalized building blocks containing the privileged 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]- and [1,5-a]pyridine cores

    Mishchuk, A., Shtil, N., Poberezhnyk, M., Nazarenko, K., Savchenko, T., Tolmachev, A. & Krasavin, M., 2 Mar 2016, In: Tetrahedron Letters. 57, 9, p. 1056-1059 4 p.

    Research output: Contribution to journalArticlepeer-review

  8. New antimycobacterial leads from multicomponent hydrazino-ugi reaction

    Lakontseva, E., Karapetian, R. & Krasavin, M., 1 Mar 2016, In: Medicinal Chemistry. 12, 2, p. 191-199 9 p.

    Research output: Contribution to journalArticlepeer-review

  9. Privileged 1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for prostate cancer therapy

    Lukin, A., Karapetian, R., Ivanenkov, Y. & Krasavin, M., 1 Mar 2016, In: Letters in Drug Design and Discovery. 13, 3, p. 198-204 7 p.

    Research output: Contribution to journalArticlepeer-review

  10. Phosphorescent Platinum(II) Complexes Featuring Chelated Acetoxime Pyrazoles: Synthetic, Structural, and Photophysical Study: Synthetic, Structural, and Photophysical Study

    Bolotin, D. S., Novikov, A. S., Kolesnikov, I. E., Suslonov, V. V., Novozhilov, Y., Ronzhina, O., Dorogov, M., Krasavin, M. & Kukushkin, V. Y., Mar 2016, In: ChemistrySelect. 1, 3, p. 456-461 6 p.

    Research output: Contribution to journalArticlepeer-review

  11. Reaction of α-tetralone, 1H-tetrazol-5-amine, and aromatic aldehydes upon microwave irradiation – A convenient method for the synthesis of 5,6,7,12-tetrahydrobenzo[h]tetrazolo[5,1-b]quinazolines

    Kantin, G. P. & Krasavin, M., 1 Jan 2016, In: Chemistry of Heterocyclic Compounds. 52, 11, p. 918-922 5 p.

    Research output: Contribution to journalArticlepeer-review

ID: 164751